Decision

Union code relating to medicinal products for human use

Effect: Passed
Result: 495 for · 57 against · 45 abstained roll call
Date: 10 April 2024, 19:17–19:19
Kind: New EU law · 1st reading

More facts (8)

Margin: by an overwhelming majority
Text: Report A-9-2024-0140
Dossier: 2023-0132
Source: Committee report by Pernille Weiss
Votes: 19 votes · 9 roll calls · 7 amendments
Requested by: S&D (1 roll call) · EPP (1 separate vote) · ECR (1 roll call, 1 split vote, 1 separate vote) · ID (1 roll call)
Sitting: Wednesday 10 April 2024
Final vote: 166975

Margin: by an overwhelming majority
Text: Report A-9-2024-0140
Dossier: 2023-0132
Source: Committee report by Pernille Weiss
Votes: 19 votes · 9 roll calls · 7 amendments
Requested by: S&D (1 roll call) · EPP (1 separate vote) · ECR (1 roll call, 1 split vote, 1 separate vote) · ID (1 roll call)
Sitting: Wednesday 10 April 2024
Final vote: 166975

Cite this page Roll-call results (EP)

Link to this page

Votes on this decision

Members on the final vote

Result

The final vote and what it means for this kind of decision.

Passed by an overwhelming majority.

Parliament adopted its position on the law.

Before the final vote, MEPs decided on 7 amendments (3 adopted, 4 rejected) and 8 parts of the text voted on separately (4 adopted, 3 rejected, 1 lapsed).

Backed by Greens, S&D, Renew, EPP and ECR; opposed by The Left and Patriots; ESN split.

Groups

Members counted in their current group: the view with groups at the date of the vote is not available right now.

Members’ votes by their current group. Majority: the most common position. Clear line: a position with at least two thirds of the group’s votes, otherwise Divided.
Group	For	Against	Abst.	Majority line	Clear line
The Left	For 5	Against 7	Abst. 1	Majority line Against	Clear line Divided
Greens	For 28	Against 1	Abst. 0	Majority line For	Clear line For
S&D	For 57	Against 2	Abst. 0	Majority line For	Clear line For
Renew	For 37	Against 0	Abst. 0	Majority line For	Clear line For
EPP	For 76	Against 3	Abst. 0	Majority line For	Clear line For
ECR	For 15	Against 3	Abst. 7	Majority line For	Clear line Divided
Patriots	For 6	Against 12	Abst. 8	Majority line Against	Clear line Divided
ESN	For 0	Against 2	Abst. 2	Majority line Tie	Clear line Divided
No group	For 2	Against 3	Abst. 0	Majority line Against	Clear line Divided

Voted against their group, 0

Members who voted otherwise than a clear line (at least two thirds of the votes cast) of their group — groups as of today: the view with groups at the date of the vote is not available right now.

Nobody voted against a clear line of their group.

Countries

The final vote by national delegation.

The breakdown by country is not available right now.

Members

Each member’s recorded position on the final roll call — groups as of today: the view with groups at the date of the vote is not available right now.

Show all 597 members

Debate speakers and how they voted

The debate speakers are not available right now.

All votes on this decision, 19

In voting order. **Result**: for–against–abstained (a show of hands has no count). **Requested by**: the groups that asked for a roll call, a split vote or a separate vote.
No.	Vote	Recorded	Result
1	Amendments by the committee responsible — put to the vote collectively Amendments by the committee responsible – put to the vote collectively	Show of hands	Adopted
2	Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote	Show of hands	Adopted
3	Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote	Show of hands	Adopted

Show the other 18 votesShow the other 16 votes

Votes on this decision, continued
No.	Vote	Recorded	Result	Requested by
2	Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote	Show of hands	Adopted
3	Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote	Show of hands	Adopted

Votes on this decision, continued
No.	Vote	Recorded	Result	Requested by
4	Amendment 85 A9-0140/2024 – Pernille Weiss – Amendments by the committee responsible – separate vote – Am 85	Roll call	382 for, 199 against, 16 abstained Adopted	Requested byroll call: ECR, S&D; separate: EPP
5	Amendment 159 — part 1 A9-0140/2024 – Pernille Weiss – Amendments by the committee responsible – separate vote – Am 159/1 Part voted on: “Text as a whole without the word: ‘potentially’”	Roll call	501 for, 81 against, 8 abstained Adopted	Requested byroll call: ECR; split: ECR
6	Amendment 159 — part 2 A9-0140/2024 – Pernille Weiss – Amendments by the committee responsible – separate vote – Am 159/2 Part voted on: “that word”	Roll call	464 for, 123 against, 11 abstained Adopted	Requested byroll call: ECR; split: ECR
7	Separate vote on Article 3, paragraph 3	Show of hands	Rejected
8	Separate vote on Article 3, paragraph 4	Show of hands	Rejected
9	Amendment 343 to Article 63, paragraph 3 A9-0140/2024 – Pernille Weiss – Article 63, § 3 – Am 343	Roll call	80 for, 509 against, 8 abstained Rejected	Requested byroll call: ID
10	Separate vote on Article 63, paragraph 3	Show of hands	Adopted
11	Separate vote on Article 69, paragraph 2, subparagraph 2	Show of hands	Adopted
12	Separate vote on Article 69, paragraph 2, subparagraph 2	Roll call	0 for, 0 against, 0 abstained Lapsed
13	Amendment 345 to Article 81, paragraph 1 A9-0140/2024 – Pernille Weiss – Article 81, § 1 – Am 345	Roll call	91 for, 490 against, 9 abstained Rejected	Requested byroll call: S&D, ID
14	Separate vote on Article 81, paragraph 1	Show of hands	Adopted
15	Amendment 346 to Article 82, paragraph 1, subparagraph 1 A9-0140/2024 – Pernille Weiss – Article 82, § 1, sub§ 1 – Am 346	Roll call	53 for, 532 against, 14 abstained Rejected	Requested byroll call: ID
16	Amendment 339 to recital 11 A9-0140/2024 – Pernille Weiss – Recital 11 – Am 339	Roll call	112 for, 464 against, 6 abstained Rejected	Requested byroll call: ID
17	Separate vote on recital 129	Show of hands	Rejected
18	Separate vote on recital 129	Show of hands	Adopted
19	Final vote A9-0140/2024 – Pernille Weiss – Commission proposal	Roll call	495 for, 57 against, 45 abstained Adopted

Roll calls requested by S&D, ECR, ID · split votes by ECR · separate votes by EPP, ECR.

Text

The text voted on.

Report A-9-2024-0140

The text in short Written by AI from the official text — check the source

Parliament's amended version of the Commission proposal for a directive on a Union code for medicinal products for human use, replacing Directive 2001/83/EC and Directive 2009/35/EC.

Read the text · Report a problem

Dossier

Where the dossier stands and its other decisions in plenary.

2023/0132(COD) · Ordinary legislative procedure

Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC

Parliament’s committee approved the deal reached with the Council on 18 March 2026; the plenary vote on it is still to come.

Show the 6 steps of the dossier

Referred to committee · 14 September 2023 (done)
Committee work · Report adopted 19 March 2024 (done)
Tabled for plenary · 21 March 2024 (done)
Plenary vote · Adopted 10 April 2024 (done)
Negotiations with the Council · Deal approved in committee 18 March 2026 (current stage)
Published as law (to come)

Lead committee: SANT · Rapporteurs: MEP #197515 (EPP), Dolors MONTSERRAT (EPP)

Connections

What this decision touches: the procedural chain, the same text, running issues, votes that split the chamber the same way.

No connections found for this decision.

Sources & citation

Where the facts on this page come from, and how to cite it.

Permalink: https://news.eu-parl.st-solutions.dev/decisions/2024-04-10/31
Official sources: Roll-call votes, sitting of 10 April 2024 (European Parliament)
Results of votes, sitting of 10 April 2024 (European Parliament)
Data source: EP Open Data API: decisions of the sitting MTG-PL-2024-04-10
Licensed CC BY 4.0.
Retrieved: 25 September 2026

Cite as

European Parliament (2024). “Union code relating to medicinal products for human use”. Decision, 10 April 2024. votingId 166975, document A-9-2024-0140, reference 2023-0132. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/decisions/2024-04-10/31 (retrieved 25 September 2026). Official sources: Roll-call votes, sitting of 10 April 2024 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-RCV_EN.html; Results of votes, sitting of 10 April 2024 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-VOT_EN.html. Data: EP Open Data API: decisions of the sitting MTG-PL-2024-04-10, https://data.europarl.europa.eu/api/v2/meetings/MTG-PL-2024-04-10/decisions?format=application%2Fld%2Bjson (CC BY 4.0).

BibTeX

@misc{epw-decision-2024-04-10-31,
  author = {{European Parliament}},
  title = {{Union code relating to medicinal products for human use}},
  year = {2024},
  date = {2024-04-10},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/decisions/2024-04-10/31}},
  url = {https://news.eu-parl.st-solutions.dev/decisions/2024-04-10/31},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Decision. votingId 166975, document A-9-2024-0140, reference 2023-0132. Official source: https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-RCV\_EN.html, https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-VOT\_EN.html. Data: EP Open Data API: decisions of the sitting MTG-PL-2024-04-10 (CC BY 4.0)}
}